These consolidated guidelines are aimed at supporting the generation of responsive person-centred data from routine national health management information systems across the HIV cascade, from prevention, testing and treatment to longer-term health care. They build upon the 2017 Consolidated guidelines on person-centred HIV patient monitoring and case surveillance, which describe information that should be collected in primary HIV patient monitoring tools, and the 2020 Consolidated HIV strategic information guidelines, which cover aggregate indicators for managing and monitoring programmes. The purpose of this guideline consolidation is to provide the recommended data elements, indicators and guidance on data systems and their use across the spectrum of health sector HIV services in one place. This document focuses on strengthening the analysis and use of routine data at each stage of the cascade and emphasizes?/addresses? person-centred HIV prevention, testing and treatment, integration of HIV-related infections, the use of routine surveillance data to measure impact, and the development and use of digital health data systems and their governance. It also identifies the gaps and limitations in these data, and the need for strengthening the use of data in all HIV-related strategic information, including population-based surveys, modelling, community-led monitoring and other sources.

Sexually transmitted infections (STIs), viral hepatitis and cervical cancer are important concerns for any country implementing HIV programmes because of their shared modes of transmission, their contribution to the risk of acquiring HIV and their substantial burden. Interventions to prevent, diagnose and treat these infections are often delivered through services integrated with or closely linked to HIV services. Collecting data on the diagnosis and treatment of related infections will help strengthen the provision of HIV prevention and treatment services and improve the health of people living with HIV and those at risk of HIV infection. Incorporating individual-level data on HIV-related infections into HIV surveillance is a new area covered in the 2022 World Health Organization Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact and is summarized in this policy brief.

The new Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact 1 aim to help countries improve how routine patient data are collected, analysed and used. They propose a minimum dataset that captures key events in an individual’s interaction with the health system, put forward priority indicators for monitoring a person’s health, and make key recommendations for data systems and data use. This policy brief summarizes the WHO guidance on digital health data in HIV services. The guidance covers several areas that are acutely important for transitioning from paper-based to digital systems while improving patient outcomes: interoperability, unique identifiers (UIDs) and privacy, security and data access and control.

Measuring HIV prevention programmes against health outcomes (such as individuals remaining HIV-negative or new HIV infections) can be challenging. This is because HIV prevention interventions can be started and stopped according to an individual’s need. Therefore, as with all other areas of the HIV response, data from multiple sources are necessary to obtain a full picture of HIV prevention service availability, access and coverage. Recent WHO guidelines focus on using routine programmatic data to track the delivery and potential impact of HIV prevention services. Routine programmatic data from prevention services also can be used to identify individuals who may be at elevated risk of HIV acquisition and so may benefit most from prevention interventions. In addition, this data can be used to follow up on whether interventions were received, and to identify and address potential barriers to accessing these services.

These recommendations include approaches for differentiated service delivery (DSD) of antiretroviral therapy (ART) that are less intensive and provide person-centred services to improve both quality and retention in care. As a result many countries have introduced or are scaling up DSD ART models. Currently, countries and partners are seeking to strengthen monitoring of differentiated ART service delivery to address implementation gaps and crucially improve patient outcomes.

The 2030 health-related Sustainable Development Goals call on countries to end AIDS as a public health threat and also to achieve universal health coverage. The World Health Organization (WHO) promotes primary health care (PHC) as the key mechanism for achieving universal health coverage, and the PHC approach is also essential for ending AIDS and reaching other Sustainable Development Goal targets. This publication helps decision-makers to consider and optimize the synergies between existing and future assets and investments intended for both PHC and disease-specific responses, including HIV.

This publication summarizes the approach proposed by WHO to collect, analyse, report, disseminate and use strategic information on viral hepatitis at the subnational, national and global levels. These guidelines strengthen person-centred monitoring – with a priority for indicators that support person-centred health services, the core prevention, diagnosis and treatment interventions. The guidelines describe the use of strategic information at various stages of the response in the context of strengthening broader health information systems. Strategic information can be defined as data collected at all service delivery and administrative levels to inform policy and programme decisions. The guidelines recommends the stepwise guidance to build country health information systems so countries use data to strengthen the scaling up of viral hepatitis programmes. The key new additions to the guidelines are: - an updated strategic information framework for chronic viral hepatitis B & C; - a new section on person-centred data monitoring for chronic viral hepatitis B & C; - a stepwise recommendation for strengthening country surveillance for viral hepatitis; and - consolidated metadata tables for viral hepatitis indicators.

This publication has been developed to provide a national framework for monitoring the health sector’s response to sexually transmitted infections and a set of core indicators to: -support countries monitor their programming for sexually transmitted infections and to identify gaps and challenges; and -facilitate regional and global tracking of the progress of WHO Member States in strengthening STI programming towards achieving the targets outlined in the global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections. The core indicators are structured around currently available STI interventions and data that are routinely collected or can be monitored at least annually. The indicators are aligned with global reporting requirements and to the targets detailed in the global health sector strategies. Collecting and analysing these data will provide a comprehensive picture of the health burden of STIs and will inform how best to allocate resources to improve the effectiveness, efficiency and equity of STI services. The publication also outlines a stepwise approach to strengthen the monitoring of STI programmes and STI surveillance.